You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oral Antidepressant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)

Recruiting
  • Treatment Resistant Depression
  • +12 more
  • Brooklyn, New York
    Maimonides Medical Center
Dec 12, 2022

Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Depressive Disorder, Treatment-Resistant
  • San Diego, California
  • +68 more
Sep 2, 2021

Depression Trial in Paris (MAP4343, Placebo)

Recruiting
  • Depression
  • Paris, France
    APHP La Pitié Salpétrière
Nov 10, 2022

Depressive Disorder, Major Trial in Alken, Aachen (Seltorexant Dose 1, Seltorexant Dose 2, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Seltorexant Dose 1
  • +3 more
  • Alken, Belgium
  • +1 more
Aug 17, 2022

MDD, Depression Trial in Pittsburgh (Buprenorphine, Naltrexone, Oral Placebo)

Recruiting
  • Major Depressive Disorder
  • Depression
  • Pittsburgh, Pennsylvania
    Bellefield Tower
Jan 26, 2022

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +49 more
May 18, 2020

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +90 more
Apr 17, 2020

Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Depressive Disorder, Treatment-Resistant
  • Birmingham, Alabama
  • +159 more
May 21, 2020

Depressive Disorder, Major, Obesity Trial in Germany (Simvastatin 40mg, Placebo oral tablet)

Recruiting
  • Depressive Disorder, Major
  • Obesity
  • Simvastatin 40mg
  • Placebo oral tablet
  • Berlin, Germany
  • +8 more
Mar 9, 2022

Depressive Disorder, Treatment-Resistant Trial (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Withdrawn
  • Depressive Disorder, Treatment-Resistant
  • Esketamine 28 mg
  • +10 more
  • (no location specified)
Nov 22, 2019

Treatment-resistant Depression Trial in Worldwide (Esketamine (Intranasal Spray), Duloxetine (Oral Antidepressant), Escitalopram

Completed
Has Results
  • Treatment-resistant Depression
  • Esketamine (Intranasal Spray)
  • +4 more
  • New Haven, Connecticut
  • +109 more
Apr 27, 2020

MDD Trial in New York (Escitalopram, Placebo oral tablet)

Completed
Has Results
  • Major Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Jun 30, 2020

Depression, MDD Trial in Pittsburgh (Naltrexone 50 Mg Oral Tablet, Placebo oral tablet)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Naltrexone 50 Mg Oral Tablet
  • Placebo oral tablet
  • Pittsburgh, Pennsylvania
    Bellefield Towers
Apr 10, 2020

Generalized Anxiety Disorder Trial in United States (Cariprazine 0.75 mg/day, Cariprazine 1.5 mg/day, Cariprazine 3.0 mg/day)

Withdrawn
  • Generalized Anxiety Disorder
  • Cariprazine 0.75 mg/day
  • +3 more
  • Little Rock, Arkansas
  • +35 more
Apr 7, 2022

Anhedonia, MDD Trial in Puerto Rico, United States (Placebo, NBI-1065846)

Recruiting
  • Anhedonia
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +11 more
Jun 27, 2022

Major Depressive Episode Trial in Vienna (Ketamine, Midazolam Hydrochloride)

Unknown status
  • Major Depressive Episode
  • Vienna, Austria
    Department of Psychiatry and Psychotherapy, Medical University o
Aug 30, 2019

MDDs Trial in Tianjin (N-acetylcysteine, comparator of N-acetylcysteine)

Recruiting
  • Major Depressive Disorders
  • Tianjin, Tianjin, China
    Tianjin Anding Hospital
Sep 21, 2022

MDD, Treatment Resistant Depression Trial in Worldwide (Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine HCl)

Not yet recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Esketamine Nasal Product
  • +3 more
  • Innsbruck, Austria
  • +12 more
Jul 25, 2023

Depression Trial in France (Ketamine, Milnacipran, Placebo)

Recruiting
  • Depression
  • Amiens, France
  • +8 more
Nov 3, 2022

Treatment Resistant MDD Trial in Canada, United States (Aripiprazole, Repetitive transcranial magnetic stimulation (rTMS),

Completed
  • Treatment Resistant Major Depressive Disorder
  • Birmingham, Alabama
  • +12 more
Apr 26, 2022

Memory Disorders, Anxiety Depression, Sleep Trial in Zarqa (Coriandrum sativum seeds)

Completed
  • Memory Disorders
  • +2 more
  • Coriandrum sativum seeds
  • Zarqa, Jordan
    Faculty of Pharmaceutical Sciences
Aug 11, 2023

MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)

Completed
Has Results
  • Major Depressive Disorder
  • PNB01 fixed dose combination of pipamperone and citalopram
  • +2 more
  • Glendale, California
  • +30 more
Mar 14, 2022

MDD Trial in Australia, United States (10 mg PRAX-114, 20 mg PRAX-114, 40 mg PRAX-114)

Completed
  • Major Depressive Disorder
  • 10 mg PRAX-114
  • +4 more
  • Lafayette, California
  • +23 more
Aug 18, 2022

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

Postpartum Depression, Mood Disorders, Anxiety Disorders Trial (Whole-Body Hyperthermia, fMRI)

Not yet recruiting
  • Postpartum Depression
  • +3 more
  • Whole-Body Hyperthermia
  • fMRI
  • (no location specified)
Nov 16, 2023